Pharma & Life Sciences
Lipid Nanoparticles Europe
The Lipid Nanoparticle Development Europe Conference discusses lipid nanoparticle development for drug delivery, including early design, analytical and CMC strategy, regulatory alignment, and manufacturing. It is for biotech, pharma, and academic experts.
The essentials
Event details
- Dates
- September 2026
- Location
- Kloé, France
- Address
- Augsburger Strasse 41, Berlin, Germany, 10789
- Organiser
- 5th Lipid Nanoparticle Development Summit Europe
- Industry
- Pharma & Life Sciences
Who attends
The audience
Connect with senior decision-makers across biopharma, biotech and academia who are actively advancing LNP-based therapeutics.
As described by the organiser
On stage
Speakers
- Ansgar Santel, Chief Executive Officer, Pantherna Therapeutics
- Suzanne Saffie-Siebert, Founder & Chief Executive Officer, SiSaf Ltd
- Shilpkala Gade, Higher Scientist, MHRA
- Chuan-En Lu, AstraZeneca
- Heinrich Haas, Chief Technology Officer, NeoVac
- Dan Shores, Partner, Rothwell Figg
- Panagiota Papadopoulou, Marie Skłodowska- Curie Postdoctoral Fellow, National Hellenic Research Foundation
- Maria Irujo, Formulation & Pharmaceutical Innovation, Advanced Biodesign
On the floor
Sponsors and partners
- BioNTech
- Leiden University
Keep planning
Related events
Spot something wrong on this page? Report a correction and we will fix it.